THREE CASES WITH BURKITT LYMPHOMA PRESENTING WITH CHOLESTASIS

YILDIRIM, Fatma Tuba; ÖZYÖRÜK, Derya; YAZAL ERDEM, Arzu; ÇAKMAKCI, Selma; SARI, Neriman; İNCESOY, Sonay; İLHAN, İnci

doi:10.1016/j.htct.2021.10.1092

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management.

Indexed in:

Web of Science, LILACS, SciELO Brazil, ESCI (Web of Science), Scopus, and PubMed/PMC

Cholestasis secondary to neoplasm is rare in children. It is also rare in Burkitt lymphoma and may be cause to treatment delay. We report 3 cases diagnosed with Burkitt lymphoma with cholestasis. All patients had jaundice and high direct biluribin levels. They were given LMB chemotherapy protocol. After COP chemotherapy, cholestasis disapperead rapidly in all patients. In conclusion, cholestasis at initial resolves rapidly with chemotherapy despite high liver function tests in Burkitt lymphoma.

Full text is only aviable in PDF

Indexed in:

Follow us:

Subscribe to our newsletter